tirzepatide surmount 3 SURMOUNT-3 study design This is a phase 3, multicenter, randomized, Psychiatric Safety of Tirzepatide: 3

Both have made a significant impact on weight management, but compounded tirzepatide stands out due to its unique benefits in helping patients lose weight effectively

Prioritize clinics that emphasize transparency, qualified medical professionals, and a complete approach to weight management

PMID: 33063385

But after 72 weeks, or 18 months, someone using 15 mg of the drug may be able to lose almost 21% of their body weight

Alarmingly, around 63% of individuals stop GLP-1 injections within the first month, primarily due to adverse side effects such as nausea, gastrointestinal discomfort, and cost-related factors

Heres how Mounjaro works: Personalized Plans: Mounjaro begins with a thorough assessment of an individuals health and lifestyle